Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced the approval of a novel formulation of the first-of-its-kind, ready-to-infuse formulation of vancomycin, ...

The Food and Drug Administration (FDA) has approved Tyzavan ™ (vancomycin injection, USP), a novel ready-to-infuse, room temperature stable formulation of vancomycin, for the treatment of various ...

Early-onset neonatal sepsis is associated with increased likelihood autism spectrum disorder (ASD) and of attention-deficit/hyperactivity disorder (ADHD), although the association with ADHD is ...